San Francisco, 07 January, Electroceuticals/Bioelectric
Medicine Market By Product (Implantable Cardioverter Defibrillators,
Pacemakers), By Application (Arrhythmia, Pain Management, Sensorineural Hearing
Loss), By Type, By End-use, & Segment Forecasts, 2018 – 2025
The global electroceuticals/bioelectricmedicine market is expected to reach USD
35.5 billion by 2025, according to a new report by Grand View Research, Inc.
Rising geriatric population is the major factor that is expected to propel
growth during the forecast period. Aging population is prone to various
diseases such as cardiac arrhythmias, Parkinson's disease, Alzheimer's disease,
epilepsy, and depression. There are various advanced electroceuticals including
implantable cardioverter defibrillators, cochlear implants, cardiac pacemakers,
and spinal cord stimulators, which can be used for the treatment of these
conditions.
Increasing investment in the
development of advanced bioelectric medicine is another major factor supporting
the growth of the electroceuticals market. For instance, in FY 2016, Medtronic,
a leading bioelectric medicine manufacturer, invested around USD 2,224 million
in R&D for development of advanced products. Technological advancements in
these products propel their adoption in treatment of chronic diseases such as
cardiac arrhythmias and Parkinson's disease. The technological advanced
electroceuticals provide high reliability and efficiency during treatment.
Access Full Research
Report On Electroceuticals/Bioelectric Medicine
Market Analysis:
Further Key Findings From The Report Suggest:
·
Implantable cardioverter
defibrillators segment was the largest revenue-generating segment of the
electroceuticals market in 2016 owing to large application of these products
for the treatment of arrhythmia
·
The implantable
electroceuticals devices segment accounted for the largest revenue share in the
bioelectric medicine market in 2016 owing to technological advancements
·
In the application segment, the
arrhythmia segment accounted for the largest share in 2016 and is expected to
maintain its dominance throughout forecast period
·
The hospitals dominated the
electroceuticals market in terms of revenue in 2016 due to the escalating
number of electroceutical devices implant procedures in hospitals
·
The North America bioelectric
medicine market is the leading regional sector and accounted for the largest
revenue share in 2016 mainly due to the existence of large number of medical
devices companies in this region
·
The Asia Pacific region is
expected to grow at a highest growth rate during the study period. The
developing healthcare infrastructure and rising healthcare awareness in the
Asian countries such as China and India is a major factor contributing to the
growth in this region
·
Some of the major players
include Medtronic; St. Jude Medical; Boston Scientific Corporation; Cochlear
Ltd.; Sonova; LivaNova PLC; Biotronik; Nevro Corp.; SECOND SIGHT; and
electroCore LLC.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
global electroceuticals market on the basis of product, type, application,
end-use, and region:
Product Outlook (Revenue, USD
Million; 2014 - 2025)
·
Implantable cardioverter
defibrillators
·
Cardiac pacemakers
·
Cochlear implants
·
Spinal cord stimulators
·
Deep brain stimulators
·
Transcutaneous electrical nerve
stimulators
·
Sacral nerve stimulators
·
Vagus nerve stimulators
·
Other bioelectric medicines
Type Outlook (Revenue, USD
Million; 2014 - 2025)
·
Implantable electroceutical devices
·
Noninvasive electroceutical
devices
Application Outlook (Revenue,
USD Million; 2014 - 2025)
·
Arrhythmia
·
Pain management
·
Sensorineural hearing loss
·
Parkinson’s disease
·
Tremor
·
Depression
·
Treatment-resistant depression
·
Epilepsy
·
Urinary and fecal incontinence
·
Others
End-Use Outlook (Revenue, USD
Million; 2014 - 2025)
·
Hospitals
·
Others
Regional Outlook (Revenue, USD
Million; 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Access Full Press Release of this Report:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
